SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-11-000044
Filing Date
2011-08-05
Accepted
2011-08-05 10:47:01
Documents
21
Period of Report
2011-08-03

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1225672
2 exhibit10-1.htm EX-10.1 305653
3 exhibit10-2image.jpg GRAPHIC 174400
4 exhibit10-2.htm EX-10.2 50550
5 exhibit10-3.htm EX-10.3 381528
6 exhibit10-4.htm EX-10.4 90921
7 exhibit10-5.htm EX-10.5 605
8 exhibit10_5.jpg GRAPHIC 194563
9 exhibit10_6.htm EX-10.6 567651
10 exhibit10-7.htm EX-10.7 69519
11 exhibit10-8.htm EX-10.8 53161
12 exhibit10-9.htm EX-10.9 71785
13 exhibit31-1.htm EX-31.1 10413
14 exhibit31-2.htm EX-31.2 10782
15 exhibi32-1.htm EX-32.1 5071
16 exhibit32-2.htm EX-32.2 5439
  Complete submission text file 0001367644-11-000044.txt   5592876

Data Files

Seq Description Document Type Size
17 ebs-20110630.xsd EX-101.SCH 13261
18 ebs-20110630.xml EX-101.INS 428406
19 ebs-20110630_cal.xml EX-101.CAL 50348
20 ebs-20110630_lab.xml EX-101.LAB 173709
21 ebs-20110630_pre.xml EX-101.PRE 98663
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 111012720
SIC: 2834 Pharmaceutical Preparations